To evaluate and compare the results of use of platelet rich fibrin in trochanteric fractures of the femur fixed with proximal femoral nail by assessing clinically and radiologically

OUTCOME OF TROCHANTERIC FEMUR FRACTURES STABILIZED WITH PROXIMAL FEMORAL NAIL WITH AND WITHOUT PLATELET RICH FIBRIN: A RANDOMIZED CONTROL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054113

Enrollment

Registered

2023-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S721- Pertrochanteric fracture

Interventions

Intervention1: Liquid Platelet rich fibrin application: 1.To assess fracture union with and without use of platelet rich fibrin in trochanteric femur fracture 2.To evaluate the clinical outcome with

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients with trochanteric femur fracture in the age group 30 - 85 years. 2.All trochanteric fractures surgically stabilized with proximal femoral nail with helical blade.

Exclusion criteria

Exclusion criteria: 1.Open trochanteric fractures 2.Pathological trochanteric fractures 3.Platelet count less than 1.2 lakhs. 4.Patient on any medication altering the platelet count or the function. 5.Immunocompromised patient. 6. Any systemic infections which impair normal healing. 7. Metabolic bone disease. 8.Patients of unsound mind or undergoing psychiatric treatment 9.HIV, diabetic, HbsAg positive patients or any patient requiring universal precaution. 10. Patients of stroke, hemiplegia.

Design outcomes

Primary

Measure	Time frame
PRIMARY: Assessment of radiological union by using RUSH score for trochanteric fractures femur. Timepoint: 1 year	—

Secondary

Measure	Time frame
Clinical status will be evaluated by assessing the functional status of patients using Harris hip score & visual analogue scale for pain & any complications related to use of PRF will be recorded. Timepoint: 1 year	—

Countries

India

Contacts

Public ContactYASH JAIN

MAULANA AZAD MEDICAL COLLEGE

sumitsural@hotmail.com9968604323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026